Shoko Kajiya

Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes

Shin Kawasoe, Yukiko Maruguchi, Shoko Kajiya et al. · BMC Pharmacology and Toxicology · 2017 · 109 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Validity of a Novel Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Diabetic Patients

Hideto Chaen, Shigesumi Kinchiku, Masaaki Miyata et al. · Journal of Atherosclerosis and Thrombosis · 2016 · 52 citations · Full text

Medicine, Endocrinology, Diabetology +13

EARLY GLYCEMIC CONTROL REDUCES LARGE-FOR-GESTATIONAL-AGE INFANTS IN 250 JAPANESE GESTATIONAL DIABETES PREGNANCIES

Hiroshi Sameshima, Masato Kamitomo, Shoko Kajiya et al. · American Journal of Perinatology · 2000 · 34 citations

Medicine, Maternal Health, Obstetrics +17

Metformin dose increase versus added linagliptin in non‐alcoholic fatty liver disease and type 2 diabetes: An analysis of the <scp>J‐LINK</scp> study

Yasuji Komorizono, Kaori Hosoyamada, Naoko Imamura et al. · Diabetes Obesity and Metabolism · 2020 · 29 citations

Medicine, Endocrinology, Pharmacology +13

Effects of Valsartan on Fibrinolysis in Hypertensive Patients With Metabolic Syndrome

Masaaki Miyata, Yoshiyuki Ikeda, Shuji Nakamura et al. · Circulation Journal · 2012 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16